H. Sanders

Histological indicators of prognosis in glioblastomas: retinoblastoma protein expression and oligodendroglial differentiation indicate improved survival

S. Love, M. Penney, L. Pobereskin, 2004, Histopathology.

Evaluation of Molecular Markers in Low-Grade Diffuse Astrocytomas: Loss of p16 and Retinoblastoma Protein Expression Is Associated With Short Survival

S. Love, M. Penney, D. Hilton, 2002, The American journal of surgical pathology.

Cannabinoid influence on cytokine profile in multiple sclerosis

J. Zajicek, E. Kaminski, H. Sanders, 2005, Clinical and experimental immunology.

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis ( CAMS study ) : multicentre randomised placebo-controlled trial

J. Zajicek, A. Nunn, D. Wright, 2022 .

Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up

A. Thompson, A. Thompson, J. Zajicek, 2005, Journal of Neurology, Neurosurgery & Psychiatry.

Emergency Dental Clinic Patients in South Devon, their Anxiety Levels, Expressed Demand for Treatment under Sedation and Suitability for Management under Sedation

H. Sanders, R. Baker, S. Farrer, 2006, Primary dental care : journal of the Faculty of General Dental Practitioners.

An audit of the quality of a referral document, designed in accordance with Scottish Intercollegiate Guidelines Network, for paediatric exodontia under general anaesthesia.

L. Anthony, H. Sanders, R. Baker, 2006, International Journal of Paediatric Dentistry.

Nettle sting for chronic knee pain: a randomised controlled pilot study.

A. White, A. Dickens, H. Sanders, 2008, Complementary therapies in medicine.

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial

J. Zajicek, A. Nunn, D. Wright, 2003, The Lancet.